Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oz Solomon

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Nature Communications|November 14, 2017
RNA editing by ADAR1 leads to context-dependent transcriptome-wide changes in RNA secondary structureOz Solomon, Ayelet Di Segni, Karen Cesarkas, et al.
Cell Death & Disease|August 5, 2022
AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signalingRenata Ferrarotto, Vasudha Mishra, Elad Herz, et al.
Nature|February 11, 2016
The dynamic N(1)-methyladenosine methylome in eukaryotic messenger RNADan Dominissini, Sigrid Nachtergaele, Sharon Moshitch-Moshkovitz, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Nature Communications|November 14, 2017
RNA editing by ADAR1 leads to context-dependent transcriptome-wide changes in RNA secondary structureOz Solomon, Ayelet Di Segni, Karen Cesarkas, et al.
Cell Death & Disease|August 5, 2022
AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signalingRenata Ferrarotto, Vasudha Mishra, Elad Herz, et al.
Nature|February 11, 2016
The dynamic N(1)-methyladenosine methylome in eukaryotic messenger RNADan Dominissini, Sigrid Nachtergaele, Sharon Moshitch-Moshkovitz, et al.
Pageof 2